KI-Beratung Beta

Gutscheinbedingungen

**Gültig bis 11.11.2026 auf Spielzeug, Schreibwaren, Filme, Geschenke & Trends, Musik, tolino eReader & Zubehör, Hörbücher und Hörbuch-Downloads, nicht preisgebundene Bücher und Kalender online auf thalia.at und in der Thalia App. Einzelne Artikel können ausgeschlossen sein. Aufgrund der Buchpreisbindung sind deutschsprachige Bücher und eBooks ausgenommen. Zusätzlich ausgenommen sind Abos & Flatrates, Games, Geschenkkarten/-boxen, Shelfies, Software, Zeitschriften sowie einzelne Artikel von tonies®. Pro Einkauf einmal einlösbar. Click & Collect nur bei Onlinevorabzahlung möglich. Keine Barauszahlung. Nicht kombinierbar mit anderen Aktionen und Gutscheinen. Gutschein wird auf max. 500€ Bestellwert angerechnet. Nicht gültig für Versandkosten und Services.

Produktbild: Therapeutic Horizons in Non-Small Cell Lung Cancer
Vorbesteller Neu

Therapeutic Horizons in Non-Small Cell Lung Cancer Ai-Driven Innovations in Diagnosis and Treatment

214,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.06.2027

Herausgeber

Vaishali Aggarwal + weitere

Verlag

Elsevier

Seitenzahl

330

Maße (L/B)

23,5/19,1 cm

Sprache

Englisch

ISBN

978-0-443-51210-0

Beschreibung

Portrait

Vaishali Aggarwal, Ph.D. at PU – IIT Ropar Regional Accelerator for Holistic Innovations, Northern S&T Cluster, Chandigarh, India, specializing in immuno-oncology research. With more than a dozen years of experience, her work focuses on immunotherapeutics, including checkpoint inhibitors like PD1 and LAG3. She investigates tumor immunology and the tumor microenvironment, exploring how immune and cancer cells interact and respond to therapies. Dr. Aggarwal has trained at PGIMER and the University of Pittsburgh and has authored numerous research articles. She has extensive mentorship and leadership experience spanning several years. Her research contributions have been widely recognized, with numerous citations and book chapters to her name, reflecting her significant impact in the field.

Dr. Vivek Kumar Garg is an Associate Professor in the Department of Medical Lab Sciences at Rayat Bahra University, India. He earned his PhD in Neurology from the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, and holds an M.Sc. in Medical Biochemistry. His research interests include cancer biology, genomics, epilepsy and neurological disorders, artificial intelligence in healthcare, biomarkers, clinical biochemistry, cardiovascular diseases, diabetes mellitus, and chronic kidney disease. His work focuses on the application of molecular, biochemical, and computational approaches to biomedical and translational research. He has contributed to research publications, academic books, and scholarly activities and has served as a reviewer and editorial board member for several international journals.

Harpal S. Buttar, PhD, is Adjunct Professor in the Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Canada, and also serves as Visiting Professor at Guru Nanak Dev University, India, and Honorary Professor at Amity University, India. He previously worked for more than four decades as a Senior Research Scientist and Assessment Officer in the Therapeutic Products Directorate of Health Canada. His research and professional interests include pharmacology, nutrition, functional foods, dietary interventions, lifestyle approaches to the prevention of cardiovascular disease, obesity, and diabetes, and the safety of drug interactions with herbal products and fruit juices. Dr. Buttar has contributed extensively to biomedical research through scholarly publications, book chapters, and international collaborations. He has served on the editorial boards of scientific journals, acted as an external examiner for postgraduate research degrees, and delivered invited lectures and seminars internationally. He is a Fellow of the International College of Nutrition and the International Academy of Cardiovascular Sciences.

Neelam Goel, Ph.D., is an Assistant Professor in the Department of Information Technology at UIET, Panjab University, Chandigarh. With over fifteen years of experience, her expertise lies in bioinformatics, biomedical signal and image processing, gene prediction, cancer multi-omics, and neurodegenerative disorders. She has authored dozens of publications across international journals, conferences, and book chapters.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.06.2027

Herausgeber

Verlag

Elsevier

Seitenzahl

330

Maße (L/B)

23,5/19,1 cm

Sprache

Englisch

ISBN

978-0-443-51210-0

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Therapeutic Horizons in Non-Small Cell Lung Cancer
  • 1. Global Epidemiology and Subtypes of NSCLC
    2. Guidelines and Management in NSCLC
    3. Risk Factors for NSCLC
    4. Molecular Pathogenesis and Diagnosis
    5. Case Studies in NSCLC Diagnosis and Treatment
    6. Advances in Diagnosis and Clinical Management
    7. Chemoresistance in NSCLC
    8. Predictive Biomarkers in NSCLC
    9. Plant-derived Markers against NSCLC
    10. Liquid Biopsies and Next-Generation Sequencing
    11. Immunotherapy and Checkpoint Inhibitors
    12. Resistance to Targeted and Immunotherapies
    13. Multi-Omics for Personalized Treatment
    14. Emerging Therapies: Cell and Vaccine Approaches
    15. AI in Early Detection of NSCLC
    16. AI Integration into Clinical Practice
    17. Global Case Studies of AI in NSCLC
    18. Future Directions and Challenges